Non-small Cell Lung Cancer (NSCLC): Current Treatment Options & the Role of ADCs

Non-small Cell Lung Cancer (NSCLC): Current Treatment Options & the Role of ADCs is organized by Antidote Education Company.

Release Date: October 19, 2023
Expiration Date: October 19, 2024

Statement of Purpose:
The overall concept for this educational initiative for community oncologists is to address unmet educational needs and positively impact practice change behaviors by accelerating the dissemination of new information. This initiative will be delivered in a pragmatic format designed to provide relevant and actionable information to the target audience where they are already engaging - on social media platforms. Antidote will work with the faculty and thought leaders to identify and disseminate findings from new studies and recently-published data relevant to Non-small Cell Lung Cancer (NSCLC).

Learning Objectives:
Upon completion of this educational activity, participants will be better able to:
• More confidently discuss the current state of the field related to include Next Generation Sequencing (NGS) testing for cancer and available NSCLC treatment options.
• Consider the evidence related to how to most effectively treat and manage patients with NSCLC.